vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and LendingClub Corp (LC). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $252.3M, roughly 1.1× LendingClub Corp). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 20.5%, a 75.9% gap on every dollar of revenue. On growth, LendingClub Corp posted the faster year-over-year revenue change (15.9% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 16.1%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
LendingClub Corporation is an American financial services company headquartered in San Francisco, California. It was the first peer-to-peer lender to register its offerings as securities with the Securities and Exchange Commission (SEC), and to offer loan trading on a secondary market. At its height, LendingClub was the world's largest peer-to-peer lending platform. The company reported that $15.98 billion in loans had been originated through its platform up to December 31, 2015.
ACAD vs LC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $252.3M |
| Net Profit | $273.6M | $51.6M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | — |
| Net Margin | 96.3% | 20.5% |
| Revenue YoY | 9.4% | 15.9% |
| Net Profit YoY | 90.3% | 341.0% |
| EPS (diluted) | $1.61 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $252.3M | ||
| Q4 25 | $284.0M | $266.5M | ||
| Q3 25 | $278.6M | $266.2M | ||
| Q2 25 | $264.6M | $248.4M | ||
| Q1 25 | $244.3M | $217.7M | ||
| Q4 24 | $259.6M | $217.2M | ||
| Q3 24 | $250.4M | $201.9M | ||
| Q2 24 | $242.0M | $187.2M |
| Q1 26 | — | $51.6M | ||
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $44.3M | ||
| Q2 25 | $26.7M | $38.2M | ||
| Q1 25 | $19.0M | $11.7M | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | $14.5M | ||
| Q2 24 | $33.4M | $14.9M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.1% | 18.8% | ||
| Q3 25 | 12.8% | 21.5% | ||
| Q2 25 | 12.2% | 21.7% | ||
| Q1 25 | 7.9% | 7.2% | ||
| Q4 24 | 59.1% | 5.1% | ||
| Q3 24 | 12.6% | 8.9% | ||
| Q2 24 | 12.6% | 10.4% |
| Q1 26 | — | 20.5% | ||
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | 16.6% | ||
| Q2 25 | 10.1% | 15.4% | ||
| Q1 25 | 7.8% | 5.4% | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | 7.2% | ||
| Q2 24 | 13.8% | 8.0% |
| Q1 26 | — | $0.44 | ||
| Q4 25 | $1.61 | $0.36 | ||
| Q3 25 | $0.42 | $0.37 | ||
| Q2 25 | $0.16 | $0.33 | ||
| Q1 25 | $0.11 | $0.10 | ||
| Q4 24 | $0.86 | $0.08 | ||
| Q3 24 | $0.20 | $0.13 | ||
| Q2 24 | $0.20 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $1.5B |
| Total Assets | $1.6B | $11.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | — | ||
| Q2 24 | $177.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $917.3M | $1.5B | ||
| Q2 25 | $822.4M | $1.4B | ||
| Q1 25 | $765.2M | $1.4B | ||
| Q4 24 | $732.8M | $1.3B | ||
| Q3 24 | $577.2M | $1.3B | ||
| Q2 24 | $516.7M | $1.3B |
| Q1 26 | — | $11.9B | ||
| Q4 25 | $1.6B | $11.6B | ||
| Q3 25 | $1.3B | $11.1B | ||
| Q2 25 | $1.2B | $10.8B | ||
| Q1 25 | $1.1B | $10.5B | ||
| Q4 24 | $1.2B | $10.6B | ||
| Q3 24 | $976.9M | $11.0B | ||
| Q2 24 | $914.1M | $9.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $-2.7B | ||
| Q3 25 | $74.3M | $-770.8M | ||
| Q2 25 | $64.0M | $-713.1M | ||
| Q1 25 | $20.3M | $-339.3M | ||
| Q4 24 | $40.4M | $-2.6B | ||
| Q3 24 | $63.2M | $-669.8M | ||
| Q2 24 | $25.0M | $-932.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-2.9B | ||
| Q3 25 | $73.9M | $-791.8M | ||
| Q2 25 | — | $-803.8M | ||
| Q1 25 | — | $-352.3M | ||
| Q4 24 | — | $-2.7B | ||
| Q3 24 | $63.2M | $-682.3M | ||
| Q2 24 | — | $-945.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | -1076.0% | ||
| Q3 25 | 26.5% | -297.4% | ||
| Q2 25 | — | -323.5% | ||
| Q1 25 | — | -161.8% | ||
| Q4 24 | — | -1237.8% | ||
| Q3 24 | 25.2% | -338.0% | ||
| Q2 24 | — | -504.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 52.7% | ||
| Q3 25 | 0.1% | 7.9% | ||
| Q2 25 | — | 36.5% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 25.0% | ||
| Q3 24 | 0.0% | 6.2% | ||
| Q2 24 | — | 6.9% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | -17.41× | ||
| Q2 25 | 2.40× | -18.68× | ||
| Q1 25 | 1.07× | -29.07× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | -46.33× | ||
| Q2 24 | 0.75× | -62.57× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
LC
Segment breakdown not available.
